Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines
Abstract Global vaccination programs using live-attenuated oral and inactivated polio vaccine (OPV and IPV) have almost eradicated poliovirus (PV) but these vaccines or their production pose significant risk in a polio-free world. Recombinant PV virus-like particles (VLPs), lacking the viral genome,...
Guardado en:
Autores principales: | Mohammad W. Bahar, Claudine Porta, Helen Fox, Andrew J. Macadam, Elizabeth E. Fry, David I. Stuart |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d14a9581b7346d2a0e7c0c7fcf06ddd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine
por: Johanna Marsian, et al.
Publicado: (2017) -
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
por: Rahnuma Wahid, et al.
Publicado: (2021) -
Polio postgraduate course
por: Editorial Office
Publicado: (1955) -
CHALLENGES FOR POLIO ERADICATION. RISK OF RE-EMERGENCY OF INFECTION IN POLIO FREE COUNTRIES
por: N. I. Romanenkova, et al.
Publicado: (2018) -
Salk Anti-Polio Vaccine
Publicado: (2017)